Our broad-based transaction experience extends across a range of situations, industries and enterprise values
Categories
Year
Type
Industry
Announced: July 29, 2019Value: $50 billionStatus: PendingFinancial advisor to Mylan on its combination with Upjohn in an all-stock Reverse Morris Trust transaction
Announced: March 18, 2019Value: $1.75 billionStatus: PendingExclusive independent financial advisor to the Special Committee of the Board of Directors of Coty in connection with JAB's tender offer
Announced: April 15, 2019Value: $1.2 billionStatus: ClosedExclusive financial advisor to Catalent on its acquisition of Paragon Bioservices from NewSpring Health Capital and Camden Partners, financed in part by $650 million of a new series of convertible preferred stock issued to Leonard Green & Partners
Announced: July 19, 2019Value: $1.1 billionStatus: PendingInvestment banker and financial advisor to Blackhawk on its RSA and Chapter 11 filing
Announced: July 31, 2019Status: ClosedExclusive financial advisor to Shields Health on equity investments made by Welsh, Carson, Anderson & Stowe and Walgreens
Announced: April 3, 2019Status: ClosedFinancial advisor to Neovia on its out-of-court recapitalization and refinancing of its balance sheet
Announced: April 2, 2019Status: ClosedExclusive investment banker to Sungard on its restructuring support agreement with a group of lenders and noteholders, and its contemplated Chapter 11 bankruptcy filing
Announced: March 11, 2019Status: ClosedInvestment banker to CTI Foods on its restructuring support agreement with members of an ad hoc group of lenders and voluntary Chapter 11 filing